LXEO Lexeo Therapeutics, Inc.
Lexeo Therapeutics, Inc. (LXEO) Institutional Ownership
What the institutions did with LXEO last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| MONTANOVA CAPITAL, LLC | 6.4M | 7.1% |
| Affinity Asset Advisors, LLC | 5.8M | 6.5% |
| BlackRock, Inc. | 5.7M | 6.4% |
| RA CAPITAL MANAGEMENT, L.P. | 5.0M | 5.6% |
| Frazier Life Sciences Management, L.P. | 4.8M | 5.4% |
| STATE STREET CORP | 4.4M | 4.9% |
| Vestal Point Capital, LP | 4.3M | 4.8% |
| Paradigm Biocapital Advisors LP | 4.2M | 4.7% |
| Jupiter Topco LLC | 4.0M | 4.4% |
| ORBIMED ADVISORS LLC | 3.9M | 4.4% |
| CITADEL ADVISORS LLC | 3.9M | 4.4% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | 3.5% |
| MILLENNIUM MANAGEMENT LLC | 2.8M | 3.2% |
| Nantahala Capital Management, LLC | 2.6M | 2.9% |
| Woodline Partners LP | 2.5M | 2.8% |
| Balyasny Asset Management L.P. | 2.4M | 2.7% |
| GOLDMAN SACHS GROUP INC | 2.1M | 2.4% |
| 683 Capital Management, LLC | 1.9M | 2.1% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | 2.0% |
| ADAR1 Capital Management, LLC | 1.6M | 1.7% |
| Avoro Capital Advisors LLC | 1.5M | 1.7% |
| Qube Research & Technologies Ltd | 1.4M | 1.5% |
| DIMENSIONAL FUND ADVISORS LP | 1.3M | 1.4% |
| Spruce Street Capital LP | 928.6K | 1.0% |
| Blackstone Inc. | 905.0K | 1.0% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | Increased | 1.3M | 6.4M | +5.1M |
| Paradigm Biocapital Advisors LP | Reduced | 6.2M | 4.2M | -2.0M |
| Point72 Asset Management, L.P. | Sold Out | 1.7M | 0 | -1.7M |
| Nantahala Capital Management, LLC | Increased | 1.2M | 2.6M | +1.4M |
| MILLENNIUM MANAGEMENT LLC | Increased | 1.6M | 2.8M | +1.2M |
| Octagon Capital Advisors LP | Sold Out | 1.1M | 0 | -1.1M |
| Qube Research & Technologies Ltd | Increased | 465.5K | 1.4M | +910.7K |
| Balyasny Asset Management L.P. | Increased | 1.6M | 2.4M | +823.2K |
| STATE STREET CORP | Increased | 3.6M | 4.4M | +786.5K |
| Affinity Asset Advisors, LLC | Increased | 5.1M | 5.8M | +757.4K |
| 683 Capital Management, LLC | Increased | 1.2M | 1.9M | +675.0K |
| BlackRock, Inc. | Increased | 5.1M | 5.7M | +628.6K |
| Aberdeen Group plc | Increased | 245.9K | 675.1K | +429.2K |
| Frazier Life Sciences Management, L.P. | Increased | 4.4M | 4.8M | +400.0K |
| Avoro Capital Advisors LLC | Reduced | 1.9M | 1.5M | -385.8K |
| NORTHERN TRUST CORP | Increased | 493.7K | 867.4K | +373.7K |
| ORBIMED ADVISORS LLC | Increased | 3.6M | 3.9M | +345.4K |
| Trexquant Investment LP | New | 0 | 314.9K | +314.9K |
| Hennion & Walsh Asset Management, Inc. | New | 0 | 265.7K | +265.7K |
| RENAISSANCE TECHNOLOGIES LLC | New | 0 | 250.4K | +250.4K |
| Woodline Partners LP | Reduced | 2.8M | 2.5M | -250.0K |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 1.5M | 1.7M | +234.2K |
| GOLDMAN SACHS GROUP INC | Increased | 1.9M | 2.1M | +199.7K |
| DIMENSIONAL FUND ADVISORS LP | Increased | 1.1M | 1.3M | +183.6K |
| TWO SIGMA INVESTMENTS, LP | Sold Out | 181.7K | 0 | -181.7K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.